Literature DB >> 7860225

Prostate tumor cell invasion: a comparison of orthotopic and ectopic models.

J D Knox1, C F Mack, W C Powell, G T Bowden, R B Nagle.   

Abstract

Interest in orthotopic models has been generated by recent reports of increased invasive and metastatic potential demonstrated by tumor cell lines following injection into their tissue of origin rather than subcutaneously. We have previously demonstrated that transfection of the tumorigenic human prostate cell line, Du-145, with the metalloproteinase matrilysin increased its ability to invade the diaphragm following an intraperitoneal injection. In this study we compare the invasive and metastatic behavior of transfected Du-145 cell lines injected into the dorsal lateral lobe of the prostate to that observed when they are injected intraperitoneally. Immunohistochemistry was used to examine 37 orthotopically injected severe combined immunodeficient mice for local invasion and metastatic lesions. In addition, the effect of injection site on the level of expression of four genes thought to influence the invasiveness of tumor cells (matrilysin, stromelysin, TIMP-1, and TIMP-2), was determined by northern analysis of orthotopic and subcutaneous tumor tissue. The results demonstrate that the level of mRNA expression of the genes examined was similar at the two sites of injection and that the invasive properties of Du-145 cells following orthotopic implantation were comparable to that observed on the diaphragm following intraperitoneal injection. The advantages of the diaphragm invasion model are: less procedure-related mortality, ease of cell delivery, and provision of an easily orientated structure in which the earliest penetration of a basal lamina can be observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7860225

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  7 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

2.  EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Authors:  T Turner; P Chen; L J Goodly; A Wells
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

3.  A human xenograft model for testing early events of epithelial neoplastic invasion.

Authors:  J McCandless; A Cress; I Rabinovitz; C Payne; G Bowden; J Knox; R Nagle
Journal:  Int J Oncol       Date:  1997-02       Impact factor: 5.650

4.  Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.

Authors:  Thirupandiyur S Udayakumar; Mimi Suzanne Stratton; Raymond B Nagle; George Timothy Bowden
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

5.  Quantitative determination of tumor cell intravasation in a real-time polymerase chain reaction-based assay.

Authors:  Emilia Mira; Rosa Ana Lacalle; Concepción Gómez-Moutón; Esther Leonardo; Santos Mañes
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Stat3 promotes metastatic progression of prostate cancer.

Authors:  Junaid Abdulghani; Lei Gu; Ayush Dagvadorj; Jacqueline Lutz; Benjamin Leiby; Gloria Bonuccelli; Michael P Lisanti; Tobias Zellweger; Kalle Alanen; Tuomas Mirtti; Tapio Visakorpi; Lukas Bubendorf; Marja T Nevalainen
Journal:  Am J Pathol       Date:  2008-05-15       Impact factor: 4.307

7.  TGF-β1 mediates the radiation response of prostate cancer.

Authors:  Chun-Te Wu; Ching-Chuan Hsieh; Tzu-Chen Yen; Wen-Cheng Chen; Miao-Fen Chen
Journal:  J Mol Med (Berl)       Date:  2014-09-18       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.